Reply  by Terkelsen, Christian Juhl et al.
D
D
f
M
I
f
f
H
v
B
s
p
a
p
p
a
i
S
H
a
a
c
p
c
a
c
m
fi
s
fi
i
a
e
n
a
g
d
h
a
r
fi
i
a
d
p
t
t
S
*
*
U
U
8
M
C
E
R
1
2
3
4
5
6
R
W
o
h
g
(
U
o
(
c
a
r
s
t
a
s
s
p
v
b
a
c
f
f
902 Correspondence JACC Vol. 53, No. 10, 2009
March 10, 2009:898–903oor-to-Balloon and
oor-to-Needle Time
or ST-Segment Elevation
yocardial Infarction in the U.S.
n a recent thought-provoking commentary, Terkelsen et al. (1)
rom Denmark recommended that the committee responsible for
urther updates to the American College of Cardiology/American
eart Association (ACC/AHA) guidelines for ST-segment ele-
ation myocardial infarction (STEMI) and the D2B (Door-to-
alloon) Alliance shift focus toward initiates that would reduce
ystem delay in primary percutaneous coronary intervention (PCI)
atients. We are in strong support of such a system-based
pproach to the management of STEMI patients at centers
roviding full-time highly skilled and efficient care for these
atients. We wish to corroborate their findings with the data
vailable online at http://www.hospitalcompare.hhs.gov/, a quality
nitiative tool created by the Centers for Medicare and Medicaid
ervices, the Department of Health and Human Services, and the
ospital Quality Alliance.
Data on over 4,000 hospitals show that 27% of patients achieve
door-to-needle (D2N) time of 30 min, and only 32% achieve
D2N time of 90 min. Our analysis reveals a concerning trend
orrelating neighborhood income with quality of care for STEMI
atients as it relates to the D2B and D2N times. Of greater
oncern is the overall rate of timely therapy, for both primary PCI
nd fibrinolytic agents. Terkelsen et al. (1) comment on the current
ontroversy regarding the acceptable PCI-related delay in deter-
ining transfer to a PCI-capable hospital for primary PCI versus
brinolysis. The meta-analysis from Nallamothu et al. (2,3)
uggested a maximum of 60 min for PCI-related delay, after which
brinolysis would result in greater benefit. This was incorporated
n the 2004 ACC/AHA STEMI guidelines (4). Further meta-
nalyses have suggested that PPCI was superior to fibrinolysis with
ven longer PCI-related delays (5,6). Current literature (2) does
ot provide a clear consensus on acceptable PCI-related delay,
lthough the 2007 Focused Update of the ACC/AHA STEMI
uidelines suggests a 40-min maximum acceptable PCI-related
elay for patients living in the catchment area of non–PCI-capable
ospitals. It also must be noted that these meta-analysis take into
ccount a 30-min D2N time. Our analysis uncovers the very poor
ates of provision of guideline-recommended care as it relates to
brinolytic therapy. We believe that a closer look at the D2N times
s warranted for a given institution before an automatic decision for
pplying that strategy can be recommended if the PCI-related
elay is prohibitive of a primary PCI strategy. This of course
resents a very complex situation because the benefit of fibrinolytic
herapy with a D2N 30 min compared with primary PCI when
here is significant PCI-related delay is unclear.
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e thank Drs. Vasaiwala and Vidovich for their interest in
ur recent viewpoint (1). Their observations from http://www.
ospitalcompare.hhs.gov/ document that many patients are still
iven in-hospital fibrinolysis at unacceptable long door-to-needle
D2N) times. We agree that the wording in the 2007 Focused
pdate of the ACC/AHA 2004 Guidelines for the Management
f patients with ST-Segment Elevation Myocardial Infarction
STEMI) (2) may be prohibitive for a primary percutaneous
oronary intervention (PCI) strategy and in some scenarios favors
fibrinolytic strategy. We still hope that the writing committee
esponsible for the updated STEMI guidelines for future revi-
ions accepts that: 1) primary PCI is superior to fibrinolysis up
o a PCI-related delay of 120 min; 2) the clock should start ticking
t the same time when balancing primary PCI against fibrinoly-
is as the choice of reperfusion strategy; 3) pre-hospital diagno-
is is important irrespective of reperfusion strategy to ensure either
re-hospital fibrinolysis or pre-hospital rerouting to high-
olume PCI centers; and 4) in-hospital fibrinolysis should only
e considered in self-presenters at rural hospitals without easy
ccess to a PCI center. We would also recommend that the
ommittee responsible for the ACC/AHA Performance Measures
or Adults With STEMI/NSTEMI consider system delay as a
uture performance measure and recommend fibrinolysis only if
he expected system delay when performing primary PCI is
m
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March 10, 2009:898–903ore than 120 min longer than expected system delay when giving
brinolysis (3).
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